Top compounds associated with response to CT45A1


Feature Type Standardized
Nominal ANOVA
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.069 0.06
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC -0.2 0.06
mRNA PX-12 CTRPv2 pan-cancer AAC -0.052 0.06
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.06
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC -0.068 0.06
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC -0.063 0.06
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.068 0.07
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.07
mRNA Irinotecan gCSI pan-cancer AAC -0.094 0.07
mRNA ML258 CTRPv2 pan-cancer AAC -0.067 0.07
Download CSV